Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04605497 · ClinicalTrials.gov registry record · NA
Time-in-range Using Continuous Glucose Monitoring Management of Gestational Diabetes Mellitus
A NA study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- NA
- Development phase
- 111
- Enrollment target
NCT04605497 is a NA study that has completed, run by Oregon Health and Science University. The registered enrollment target is 111 participants.
The verdict
NCT04605497, a NA study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- NA
- Development phase
- 111 participants
- Enrollment target
Study Summary
The continual glucose is going to increase time-in-range compared to the standard method in women with gestational diabetes
Interventions
- DIAGNOSTIC_TEST Continuous glucose monitoring (CGM)
- DIAGNOSTIC_TEST Self-Capillary Blood Glucose Monitoring (SCBG)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 111 participants |
| Start Date | 2021-02-11 |
| Est. Completion | 2023-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04605497
The ClinicalTrials.gov registry entry for NCT04605497 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 111 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Continuous glucose monitoring (CGM) is the first listed.
NCT04605497 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04605497 about?
NCT04605497 is a clinical study titled "Time-in-range Using Continuous Glucose Monitoring Management of Gestational Diabetes Mellitus". The continual glucose is going to increase time-in-range compared to the standard method in women with gestational diabetes
What is the current status of trial NCT04605497?
This trial is currently completed. It is a NA study. The enrollment target is 111 participants. The study started on 2021-02-11. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT04605497?
The interventions under investigation include: Continuous glucose monitoring (CGM) (DIAGNOSTIC_TEST), Self-Capillary Blood Glucose Monitoring (SCBG) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04605497?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.